Stratos Wealth Partners’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,816
Closed -$175K 1196
2022
Q4
$175K Buy
+1,816
New +$196K ﹤0.01% 1055

Other funds holding PRPH

Stratos Wealth Partners's PRPH Position: Q1 2023 in Review

Stratos Wealth Partners sold out of ProPhase Labs (PRPH) in Q1 2023, closing a stake of 1,816 shares — an estimated $175K sold.

Stratos Wealth Partners first reported a position in PRPH in Q4 2022 and held it in 1 quarter. The position peaked at $175K in Q4 2022. 39 funds tracked by Wall St. Rank hold PRPH as of Q1 2023.

  • Stratos Wealth Partners reported no remaining ProPhase Labs position as of Q1 2023 after selling out during the quarter.
  • Stratos Wealth Partners sold 1,816 ProPhase Labs shares in Q1 2023, an estimated $175K.
  • Stratos Wealth Partners first reported a position in ProPhase Labs in Q4 2022 and held it in 1 quarter.
  • Stratos Wealth Partners's ProPhase Labs position peaked at $175K in Q4 2022.
  • 39 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2023.

Based on Stratos Wealth Partners's 13F filing for Q1 2023, filed 27 Apr 2023.